4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-052283
Chief Financial Officer sold 10,000 shares at an average $52.69 ($526,913)
- Chief Financial Officer acquired 10,247 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-05-01 | Option exercise 10b5-1 | +10,247 | $15.60 | $159,836 | 23,938 | D |
| Thunen Shelley B Chief Financial Officer | 2024-05-01 | Sale 10b5-1 | −9,620 | $52.68 | $506,759 | 14,318 | D |
| Thunen Shelley B Chief Financial Officer | 2024-05-01 | Sale 10b5-1 | −380 | $53.04 | $20,154 | 13,938 | D |
| Derivatives | |||||||
| Thunen Shelley B Chief Financial Officer | 2024-05-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 46,805 | D | ||
| Open-market sales · 10,000 sh · avg $52.69 · $526,913 | |||||||
Loading xslF345X05/ownership.xml…